IBUKUNOLUWA AYANLEYE: Open Payments
NPI 1265138853 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,317 in 124 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $1,280 · 2025 $3,317
Food & beverage: $3,086Education: $231
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 12 | $503 |
| Otsuka America Pharmaceutical, Inc. | 10 | $402 |
| ABBVIE INC. | 14 | $327 |
| E.R. Squibb & Sons, L.L.C. | 12 | $296 |
| Lundbeck LLC | 15 | $289 |
| Janssen Pharmaceuticals, Inc | 10 | $276 |
| Neurocrine BioSciences, Inc. | 7 | $273 |
| Axsome Therapeutics, Inc. | 8 | $212 |
| Supernus Pharmaceuticals, Inc. | 6 | $174 |
| Alkermes, Inc. | 11 | $167 |
Products named: ABILIFY MAINTENA, VRAYLAR, COBENFY, INVEGA SUSTENNA, INGREZZA, AUSTEDO XR, Auvelity, REXULTI.
Industry payments across MD — which companies pay providers there.
